The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.
Public meetings that systematically obtain the patient perspective on specific diseases and their treatments
Medical Product Type Covered
Biologics, Drugs
Meeting Frequency
Varies
Participant Status
Patients, Caregivers and Advocates that serve as Special Government Employees
Topics Covered
Symptoms and daily impacts that matter most to patients, patient perspectives on current treatment approaches, and topics such as clinical trial considerations and meaningful benefit may also be explored
To allow patient organizations to identify and organize patient-focused collaborations to generate public input on other disease areas, using the process established through FDA-led PFDD meetings as a model
Medical Product Type Covered
Biologics, Drugs
Meeting Frequency
Varies
Participant Status
Patients, Caregivers and Advocates
Topics Covered
FDA welcomes host organizations to have public meetings to discuss symptoms and daily impacts that matter most to patients, patient perspectives on current treatment approaches, and topics such as clinical trial considerations and meaningful benefit may also be explored.
Provides advice to the Commissioner or designee, on complex issues relating to medical devices, the regulation of devices, and their use by patients in a public advisory committee meeting
Medical Product Type Covered
Devices
Meeting Frequency
Annually
Participant Status
Patients, Caregivers and Advocates that serve as Special Government Employees**
Provides advice to the Commissioner or designee, on complex issues relating to medical devices, the regulation of devices, and their use by patients in a public advisory committee meeting
Medical Product Type Covered
Biologics, Devices, Drugs
Meeting Frequency
Annually
Participant Status
Patients, Caregivers and Advocates that serve as Special Government Employees**
* This list is not inclusive of all FDA Patient Engagement Initiatives.
** Special Government Employees are appointed when conflict of interest restrictions need to be applied to participants for topics that cover specific products or regulatory issues.
